Keywords: Cypress Bioscieces, Ramius, Raises take over offer, M&A

Ramius increases unsolicited offer for Cypress Biosciences to $5.50 a share

Article | 13 December 2010

Print This

Shares in USA-based biotech firm Cypress Biosciences (Nasdaq: CYPB) leapt 20% to $4.88 on Friday after investment advisor Ramius V&O ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in